News & Updates

Women undergoing medically assisted reproductive treatment seem to be at heightened risk of hormone-related cancers, as suggested in a study.

A subgroup analysis of the phase IV POSEIDON group 2 study presented at ESHRE 2026 shows the noninferiority of mild ovarian stimulation to an intense approach to yield good-quality blastocysts (GQBs) in in vitro fertilization (IVF).

New drug applications approved by US FDA as of 1-15 July 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Pregnant women who are using lithium are at increased risk of spontaneous preterm birth, according to a retrospective study.

Women who work shifts or irregular hours are at significantly higher risk of developing rheumatoid arthritis (RA) than those who work regular daytime hours, according to a recent study presented at EULAR 2026.

A study from Singapore identified an epidemiological paradox: Low birth weight (LBW; <2,500 g) rates were lower among socioeconomically disadvantaged foreign-born mothers than native-born mums.

Treatment with hydroxychloroquine does not appear to improve the chances of livebirth for women with a history of three consecutive miscarriages, according to a phase III study.